Showing results (251-260 of 1,186) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|July 2, 2024
Futility Interim Analysis Based on Probability of Success Using a Surrogate EndpointRonan Fougeray, Loïck Vidot, Marco Ratta, et al.Pharmaceutical Statistics|June 26, 2024
T3 + 3: 3 + 3 Design With Delayed OutcomesJiaying Guo, Mengyi Lu, Isabella Wan, et al.Pharmaceutical Statistics|October 23, 2023
Enrollment forecast for clinical trials at the portfolio planning phase based on site-level historical dataSheng Zhong, Yunzhao Xing, Mengjia Yu, et al.Pharmaceutical Statistics|October 23, 2023
Frequentist and Bayesian tolerance intervals for setting specification limits for left-censored gamma distributed drug quality attributesRichard O MontesPharmaceutical Statistics|April 11, 2024
Predictive Ppk calculations for biologics and vaccines using a Bayesian approach - a tutorialJos Weusten, Jianfang HuPharmaceutical Statistics|August 12, 2023
Adaptive designs for best treatment identification with top-two Thompson sampling and accelerationJixian Wang, Ram TiwariPharmaceutical Statistics|August 9, 2023
"Super-covariates": Using predicted control group outcome as a covariate in randomized clinical trialsBjörn Holzhauer, Emmanuel Taiwo AdewuyiPharmaceutical Statistics|January 12, 2024
Going beyond probability of success: Opportunities for statisticians to influence quantitative decision-making at the portfolio levelStig-Johan Wiklund, Katharine Thorn, Heiko Götte, et al.Pharmaceutical Statistics|January 17, 2024
Transporting randomized trial results to estimate counterfactual survival functions in target populationsZhiqiang Cao, Youngjoo Cho, Fan LiPharmaceutical Statistics|March 12, 2024
Optimal sample size allocation for two-arm superiority and non-inferiority trials with binary endpointsMarietta Kirchner, Stefanie Schüpke, Meinhard KieserPageof 119